Melbourne executive Nathan Smith will take the reins as CEO at NeuroScientific Biopharmaceuticals, bringing his strategic and commercial nous as the company gears up to release its innovative StemSmart stem cell technology. This is the Perth-based biotech's second heavy-hitting appointment, after it recruited a well-credentialled chief medical officer in Perth-based paediatric haematologist and oncologist Dr Catherine Cole.
NeuroScientific Biopharmaceuticals has snagged a well-credentialled WA haematologist and oncologist as its chief medical officer. The company is banking on Dr Catherine Cole's decades of clinical leadership and trials experience to help it roll out its innovative stem cell therapy. A trial is underway to test its stem cell technology to treat patients with a difficult-to-treat complication of Crohn's disease.
